Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Hank who wrote (2314)	2/24/2000 4:28:00 PM
From: out_of_the_loop	Read Replies (1) \| Respond to of 5582

Do your own dd, Hank. It is in the abstract that you do not acknowledge. Since your training is better than Dr. Hirt's Harvard medical training and status better than Dr. Hirt's UCLA faculty status, you are on your own to say and do whatever you wish, even call this debt-free profitable company a scam as it prepares international distribution and ramping of nicotine gum (do some research on its medical uses, too). Since you think GelTech's initial study is worthy of the National Enquirer and term the USC scientists as "promoters", it is basically not worth my time to try and address your concerns when they are presented so facetiously and immodestly. I do not understand your bitter tone but will attribute it to the stock price rather than anything personal. What makes you think Dr. Hirt's study is the one described in the previous PR?